Health Care & Life Sciences » Pharmaceuticals | Krebs Biochemicals & Industries Ltd.

Krebs Biochemicals & Industries Ltd.

Krebs Biochemicals & Industries Ltd.
Stock Exchange Bombay Stock Exchange Prices
EPS
INR12.49
Market Cap
INR1.55 B
Shares Outstanding
13.74 M
Public Float
-

Profile

Address
Plot No.34, 8-2-577/B
Hyderabad TS 500034
India
Employees -
Website http://krebsbiochem.com
Updated 09/14/2018
Krebs Biochemicals & Industries Ltd. engages in the manufacture and selling of pharmaceutical ingredients and intermediates. It provides synthetic products, including lavastatin, simvastatin and ephedrine as well as pseudo ephedrine. The company was founded by Ravindranath Tagore Ravi on December 2, 1991 and is headquartered in Hyderabad, India.

Financials

View All
Created with Highcharts 5.0.14Krebs Biochemicals & Industries Ltd.Net Income. Fiscal year is April-March. All values INR Thousands.121 660121 660186 312186 312163 204163 204160 493160 493178 249178 24920132015201620172018050k100k150k200k
Created with Highcharts 5.0.14Krebs Biochemicals & Industries Ltd.Sales/Revenue. Fiscal year is April-March. All values INR Thousands.138 256138 2560012 53812 53832 21132 211337 791337 791201320152016201720180100k200k300k400k

Avinash Ravi
Managing Director & Executive Director
Manish Jain
Non-Executive Director